India’s largest online pharmacy bought a rival for 45.5 billion rupees ($613 million), marking a rare purchase of a listed company in the country by an unlisted firm valued at over $1 billion, called unicorns because they are so few.
API Holdings Pvt.’s PharmEasy acquired a 66.1% stake in
The combined firm will be able to provide diagnostics and deliver medicines to more than 100 million Indians ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.